Orthofix Medical Statistics
Share Statistics
Orthofix Medical has 38.21M shares outstanding. The number of shares has increased by 2.16% in one year.
| Shares Outstanding | 38.21M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.1% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 36.84M |
| Failed to Deliver (FTD) Shares | 6 |
| FTD / Avg. Volume | 0% |
Short Selling Information
The latest short interest is 1.12M, so 2.94% of the outstanding shares have been sold short.
| Short Interest | 1.12M |
| Short % of Shares Out | 2.94% |
| Short % of Float | 3.05% |
| Short Ratio (days to cover) | 4.64 |
Valuation Ratios
The PE ratio is -3.27 and the forward PE ratio is -1925.
| PE Ratio | -3.27 |
| Forward PE | -1925 |
| PS Ratio | 0.66 |
| Forward PS | 0.7 |
| PB Ratio | 0.83 |
| P/FCF Ratio | -4.59 |
| PEG Ratio | n/a |
Enterprise Valuation
Orthofix Medical Inc. has an Enterprise Value (EV) of 591.55M.
| EV / Earnings | -3.91 |
| EV / Sales | 0.79 |
| EV / EBITDA | -7.45 |
| EV / EBIT | -4.25 |
| EV / FCF | -5.49 |
Financial Position
The company has a current ratio of 2.54, with a Debt / Equity ratio of 0.16.
| Current Ratio | 2.54 |
| Quick Ratio | 1.2 |
| Debt / Equity | 0.16 |
| Total Debt / Capitalization | 13.61 |
| Cash Flow / Debt | -0.48 |
| Interest Coverage | -16.12 |
Financial Efficiency
Return on equity (ROE) is -0.25% and return on capital (ROIC) is -19.33%.
| Return on Equity (ROE) | -0.25% |
| Return on Assets (ROA) | -0.16% |
| Return on Capital (ROIC) | -19.33% |
| Revenue Per Employee | 456.94K |
| Profits Per Employee | -92.65K |
| Employee Count | 1.63K |
| Asset Turnover | 0.81 |
| Inventory Turnover | 1.17 |
Taxes
| Income Tax | 2.72M |
| Effective Tax Rate | -0.02 |
Stock Price Statistics
The stock price has increased by 37.25% in the last 52 weeks. The beta is 1.05, so Orthofix Medical 's price volatility has been higher than the market average.
| Beta | 1.05 |
| 52-Week Price Change | 37.25% |
| 50-Day Moving Average | 17.96 |
| 200-Day Moving Average | 15.67 |
| Relative Strength Index (RSI) | 41.97 |
| Average Volume (20 Days) | 251.49K |
Income Statement
In the last 12 months, Orthofix Medical had revenue of 746.64M and earned -151.40M in profits. Earnings per share was -4.12.
| Revenue | 746.64M |
| Gross Profit | 486.27M |
| Operating Income | -139.11M |
| Net Income | -151.40M |
| EBITDA | -79.45M |
| EBIT | -139.11M |
| Earnings Per Share (EPS) | -4.12 |
Balance Sheet
The company has 37.76M in cash and 134.20M in debt, giving a net cash position of -96.44M.
| Cash & Cash Equivalents | 37.76M |
| Total Debt | 134.20M |
| Net Cash | -96.44M |
| Retained Earnings | -150.14M |
| Total Assets | 867.87M |
| Working Capital | 224.32M |
Cash Flow
In the last 12 months, operating cash flow was -45.75M and capital expenditures -62.05M, giving a free cash flow of -107.80M.
| Operating Cash Flow | -45.75M |
| Capital Expenditures | -62.05M |
| Free Cash Flow | -107.80M |
| FCF Per Share | -2.94 |
Margins
Gross margin is 6.51K%, with operating and profit margins of -1.86K% and -2.03K%.
| Gross Margin | 6.51K% |
| Operating Margin | -1.86K% |
| Pretax Margin | -1.99K% |
| Profit Margin | -2.03K% |
| EBITDA Margin | -10.64% |
| EBIT Margin | -18.63% |
| FCF Margin | -14.44% |
Dividends & Yields
OFIX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -23.69% |
| FCF Yield | -16.22% |
Analyst Forecast
The average price target for OFIX is $23, which is 32.3% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $23 |
| Price Target Difference | 32.3% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
Scores
| Altman Z-Score | 1.61 |
| Piotroski F-Score | 3 |